Delgocitinib

ATC D11AH11 · 6 markets · 7 records

Delgocitinib 6 markets · 7 records Forms

AU 2 records · 2 strengths

20 mg/gtopicalANZUPGO delgocitinib 20 mg/g cream tube unknown

Records without a stated strength · 1 Anzupgo

US 1 records · 1 strengths

20 mgtopicalAnzupgo also in GB·CA·ES

GB 1 records · 1 strengths

20 mgtopicalAnzupgo 20mg/g cream also in US·CA·ES

CA 1 records · 1 strengths

20 mgtopicalAnzupgo also in US·GB·ES

ES 1 records · 1 strengths

20 mgtopicalAnzupgo also in US·GB·CA

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Anzupgo

Side-by-side table

Strength / form / release	US	GB	CA	AU	ES	EU
20 mg topical	Anzupgo	Anzupgo 20mg/g cream	Anzupgo	not recorded	Anzupgo	not recorded
20 mg/g topical	not recorded	not recorded	not recorded	ANZUPGO delgocitinib 20 mg/g cream tube	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Anzupgo	not recorded	Anzupgo

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.